SCHEMBL145014

SCHEMBL145014

CC[N+](C(C)C)(C(C)C)C(C)C

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
KCNA1 Q09470 1/20 0.33
KDM4E B2RXH2 1/20 0.31
PMP22 Q01453 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL19181191 0.82
SCHEMBL2085974 0.79
SCHEMBL2766443 0.69 TSHR (0.41) TSHR
SCHEMBL1832260 0.69 SLC22A1 (0.41) TSHR
Bromide SCHEMBL14890343 0.67 TSHR (0.39) TSHR
Water SCHEMBL10899203 0.67 TSHR (0.39) TSHR
Hydrochloric Acid SCHEMBL17255868 0.67 TSHR (0.39) TSHRKDM4EPMP22ATM
SCHEMBL349518 0.67 TSHR (0.33) TSHRNFKB1KCNA1KDM4EPMP22
SCHEMBL51908 0.67 TSHR (0.33) TSHRNFKB1KCNA1KDM4EPMP22
SCHEMBL1834022 0.65 SLC22A1 (0.37) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2388246-B1 Two liquid component system and a process using such system for obtaining a peroxyacid (peracetic acid) MYRIEL S R L (IT) 2017-11-29 EP claimed
EP-2388246-A1 Two liquid component system and a process using such system for obtaining a peroxyacid (peracetic acid) Myriel s.r.l. (IT) 2011-11-23 EP claimed
US-8038727-B2 Treating textile materials with polyorganosiloxanes BLUESTAR SILICONES FRANCE (FR) 2011-10-18 US claimed
EP-3475275-B1 3-ARYL AND HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS MERCK SHARP & DOHME LLC (US) 2024-04-10 EP disclosed
US-11066396-B2 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors MERCK SHARP & DOHME CORP. (US) 2021-07-20 US disclosed
EP-3042939-B1 ADHESIVE COMPOSITION TOAGOSEI CO LTD (JP) 2021-06-23 EP disclosed
EP-3042933-B1 CURABLE RESIN COMPOSITION TOAGOSEI CO LTD (JP) 2020-09-30 EP disclosed
WO-2020071553-A1 ADHESIVE COMPOSITION FOR ASSEMBLING SPEAKER, METHOD FOR ASSEMBLING SPEAKER, AND SPEAKER 東亞合成株式会社 2020-04-09 WO disclosed
EP-2896668-B1 2-CYANOACRYLATE-BASED ADHESIVE COMPOSITION TOAGOSEI CO LTD (JP) 2019-11-13 EP disclosed
CN-107108771-B Two-liquid type solidification compound 东亚合成株式会社 2019-08-16 CN disclosed
EP-3231818-B1 TWO-PART CURABLE COMPOSITION TOAGOSEI CO LTD (JP) 2019-08-14 EP disclosed
US-20060007629-A1 Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium MITSUBISHI CHEMICAL CORPORATION (JP) 2006-01-12 US disclosed
CN-1708817-A Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium MITSUBISHI CHEM CORP (JP) 2005-12-14 CN disclosed
EP-1564768-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM Mitsubishi Chemical Corporation (JP) 2005-08-17 EP disclosed
CN-1511327-A Electrolyte for electrolytic capacitor and electrolytic capacitor using the same ������ѧ��ʽ���� 2004-07-07 CN disclosed
US-20040095708-A1 Electrolyte for electolytic capacitor and electrolytic capacitor using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2004-05-20 US disclosed
EP-1394824-A1 ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR USING IT Mitsubishi Chemical Corporation (JP) 2004-03-03 EP disclosed
US-5565606-A Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method HOECHST AKTIENGESELLSCHAFT (DE) 1996-10-15 US disclosed
EP-0264802-B1 SYNTHESIS OF PEPTIDE-AMINOALKYL AMIDES AND PEPTIDE HYDRAZIDES BY THE SOLID PHASE METHOD HOECHST AKTIENGESELLSCHAFT (DE) 1992-12-09 EP disclosed
EP-0264802-A2 Synthesis of peptide-aminoalkyl amides and peptide hydrazides by the solid phase method HOECHST AKTIENGESELLSCHAFT (DE) 1988-04-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11066396-B2 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors HDAC6, HDAC1, HDAC5 TSHR 1107/4885NFKB1 2837/4885KCNA1 2062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.